{"status": "Ok", "redirect_url": "https://www.prnewswire.com//news-releases/fda-provides-further-regulatory-guidance-to-acurx-pharmaceuticals-for-the-ibezapolstat-clinical-development-program-including-the-potential-for-a-single-phase-3-trial-registration-plan-and-a-trial-design-to-support-both-treatment-302840633.html", "message": "News view counter 862949 successfully enlarged"}